drugset / Trial / NCT00611169

The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction

NCT00611169

Phase 4 Completed 40 enrolled Samsung Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study to investigate whether the administration of high-dose tirofiban before primary PCI could reduce myocardial infarct size, using analysis of contrast-enhanced magnetic resonance imaging.

Timeline

Start
2006-01
Primary completion
2007-02
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Tirofiban Other / unclassified 0.15 ug/kg